| NCOAX | RTEHX | NCOAX / RTEHX | |
| Total Expense Ratio | 1.01 | 1.12 | 90% |
| Annual Report Gross Expense Ratio | 1.08 | 1.12 | 96% |
| Fund Existence | 16 years | 11 years | - |
| Gain YTD | 6.154 | 6.139 | 100% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 2500 | 250 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 561M | 26.2B | 2% |
| Annual Yield % from dividends | 7.58 | 5.88 | 129% |
| Returns for 1 year | 6.85 | 6.45 | 106% |
| Returns for 3 years | 31.70 | 30.26 | 105% |
| Returns for 5 years | 28.40 | 31.31 | 91% |
| Returns for 10 years | 73.88 | 73.69 | 100% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XVOL | 23.65 | N/A | N/A |
| Acruence Active Hedge US Equity ETF | |||
| LCDS | 63.76 | N/A | N/A |
| JPMorgan Fundamental Data Sci Lg Cor ETF | |||
| PJP | 101.57 | -0.71 | -0.69% |
| Invesco Pharmaceuticals ETF | |||
| DSL | 11.49 | -0.10 | -0.86% |
| DOUBLELINE Income SOLUTIONS FUND | |||
| LEAD | 74.62 | -2.20 | -2.86% |
| Siren DIVCON Leaders Dividend ETF | |||